Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Meatly completes £10.4 million Series A funding

7th May 2026 16:04

RNS Number : 4852D
Agronomics Limited
07 May 2026
 

 Agronomics Limited

("Agronomics" or the "Company")

 

Portfolio company Meatly completes £10.4 million Series A funding round

Proceeds to fund 20,000-litre facility in London

 

Agronomics (AIM: ANIC), the leading AIM listed clean food company, announces that its portfolio company, Good Dog Food Limited, trading as Meatly ("Meatly"), has completed a £10.4 million Series A funding round. Participants included Clean Growth Fund, Oyster Bay, JamJar Ventures, Jim Mellon and existing investors.

 

The financing follows £7.1 million of seed funding from Agronomics and Pets at Home, bringing total funding raised by Meatly to £17.5 million.

 

Since launching in 2022, Meatly has focused on reducing the cost of cultivated meat production. In 2024, it announced a reduction in the cost of its protein-free medium to £0.22 per litre and, in 2025, an approximately tenfold reduction in bioreactor costs. Following regulatory authorisation in 2024, Meatly launched the world's first cultivated pet food in a commercial trial in 2025.

 

The new funding will support development of a 20,000-litre bioreactor facility in London, which Meatly expects to be the largest of its kind in Europe. Fit-out is expected to commence immediately, with product launches anticipated in 2027.

Owen Ensor, CEO, Meatly, comments: "This investment marks a powerful endorsement - not just of Meatly, but of Britain's foodtech and biotech sectors. Meatly has one focus - to make commercially viable cultivated meat a reality. Over the last four years, Meatly's pioneering team has systematically focused on reducing key costs and building the strongest possible technical foundation for growth. Now we have our own industry-leading technology, and we are ready to scale."

 

Ensor continued, "This step will allow us to prove commercial viability at scale and start to continually produce Meatly Chicken to the UK pet food market."

 

Jim Mellon, Executive Chair at Agronomics and Chair and Founding Investor at Meatly said: "The market opportunity for sustainable and high-quality protein is enormous, but success in this category ultimately comes down to one thing: bringing down the cost of production. The team at Meatly has consistently cracked this challenge, reducing costs by building their own bioreactors, developing their own culture medium, and staying focused on what it takes to scale.

 

That combination of technical rigour and financial discipline is exactly what wins in this market, that's why we founded the company and continue to support them. This approach has earned Meatly fresh capital from new investors as the company scales production, aiming to build a more resilient, secure and sustainable protein supply chain across the UK and Europe."

 

Agronomics has invested £1.1 million into Meatly since inception. Following completion of the Financing, Agronomics will carry its position in Meatly at £3.2 million (31/12/2025: £4.5 million). Agronomics has an equity ownership in Meatly of 11.57% on a fully diluted basis.

 

 

ENDS

 

About Meatly 

Meatly was founded in 2022. The company produces ethical and sustainable cultivated meat products without compromising on essential nutritional benefits. In the last four years, they have created industry leading technology and became the first company to ever sell cultivated meat in Europe. Their current focus is on the pet food market.

About Agronomics

Agronomics is a leading London-listed company focused on investment opportunities within the field of clean food. The Company has established a portfolio of over 20 companies developing technologies that produce food and materials historically derived from animals, offering solutions for improved sustainability, human health, and food security.

A full list of Agronomics' portfolio companies is available at www.agronomics.im.

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF THIS ANNOUNCEMENT, VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

For further information, please contact:

 

Agronomics Limited

Beaumont

Cornish Limited

Cavendish Capital

Markets

Limited

Canaccord Genuity

Limited

33Seconds

Limited

The Company

Nomad

Joint Broker

Joint Broker

Public Relations

Jim Mellon

Denham Eke

Roland Cornish

James Biddle

Giles Balleny

Michael Johnson

Andrew Potts

Harry Pardoe

Jack Ferris

Joel Watson

+44 (0) 1624 639396

[email protected]

+44 (0) 207 628 3396

+44 (0) 207 397 8900

+44 (0) 207 523 8000

[email protected]

 

Nominated Adviser Statement

Beaumont Cornish Limited ("Beaumont Cornish"), is the Company's Nominated Adviser and is authorised and regulated in the United Kingdom by the Financial Conduct Authority. Beaumont Cornish's responsibilities as the Company's Nominated Adviser, including a responsibility to advise and guide the Company on its responsibilities under the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed solely to the London Stock Exchange. Beaumont Cornish is not acting for and will not be responsible to any other persons for providing protections afforded to customers of Beaumont Cornish nor for advising them in relation to the proposed arrangements described in the announcement or any matter referred to in it.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEDLFBQELBBBF

Related Shares:

Agronomics
FTSE 100 Latest
Value10,276.95
Change-161.71